FCI Acquires MergeOptics' Assets to Complement its High-Speed I/O Portfolio

FCI, a leading manufacturer and provider of connector and cable assembly solutions to the data, communications, consumer, industrial and medical markets. has acquired the assets of MergeOptics (www.mergeoptics.com), a manufacturer of active optical cables (AOCs) and optical transceivers. This acquisition will allow FCI to leverage MergeOptics' leadership position in AOCs to complement FCI's passive and active copper cables assemblies to address data and communications market applications.

Data centers and high performance computing applications require that the data-rate performance per channel as defined by various standards be maintained over long lengths of cable. Current applications feature both copper high-speed I/O solutions for short-to-moderate lengths. Applications that require longer cable lengths employ the use of fiber optics via either active optical cables or through the use of transceivers. The market requirements for increased speed and port density continue to drive suppliers towards higher speed solutions increasing the utilization of active optical cables and transceivers as the market drives toward 25Gb/s per channel high-speed I/O solutions.

"MergeOptics' leading position in active optical cables extends FCI's existing high-speed I/O portfolio of passive and active copper solutions," said Pete Curwen, corporate vice president and general manager of FCI - Electronics Division. "With this complete portfolio of I/O product solutions, we will be able to provide our customers with more complete and innovative solutions to meet their needs today and in the future."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.